Market Size of Netherlands Neurology Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 4.40 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Netherlands Neurology Devices Market Analysis
The Netherlands Neurology Devices Market is expected to grow with a CAGR of 4.4% during the forecasted period.
The COVID-19 pandemic has affected the neurology devices market in the Netherlands significantly. The treatment for neurological diseases faced several complications during the lockdown in the country. As per the article published in BioMed Central (BMC) Journal in January 2022 titled, 'Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands,' approximately 14% decrease in the neurology treatment was observed during the year 2020-2021. This has affected the overall utilization of neurology devices in the Netherlands. However, a post-covid scenario in the country is different than that of the year 2020 as most of the elective surgeries are being performed in the country, as stated by the Department of Neurosurgery and Neurology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands in January 2022. Hence, with the above-mentioned factors, it is observed that COVID-19 had a negative impact on the neurology devices market in the Netherlands.
The key factors propelling the growth of this market are an increase in the incidence of neurological disorders, huge investments by private players in neurology devices, and an increase in R&D in the field of Neurotherapy. According to the World Ageing 2021 report, the number of people who are above 65 years of age in the Netherlands was 2,618,874 in 2021 which is projected to reach 4.295 million (24.6%) in 2030. The number of geriatric population is expected to increase in coming years who are more prone to disorders such as cognitive impairment and dementia which ultimately rises the growth of the market in near future.
Thus, owing to the above factors the market is expected to show significant growth over the forecast period.
Netherlands Neurology Devices Industry Segmentation
As per the scope of the report, neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury. The Netherlands Neurology Devices Market is segmented by Type of Device (Cerebrospinal Fluid Management Device, Interventional Neurology Device, Neurosurgery Device, Neurostimulation Device, and Other Type of Devices). The report offers the value (in USD million) for the above segments.
| By Type of Device | |
| Cerebrospinal Fluid Management Devices | |
| Interventional Neurology Devices | |
| Neurosurgery Devices | |
| Neurostimulation Devices | |
| Other Types of Devices |
Netherlands Neurology Devices Market Size Summary
The Netherlands Neurology Devices Market is poised for growth, driven by an increasing incidence of neurological disorders and substantial investments in the sector. The market experienced a setback during the COVID-19 pandemic, which led to a decrease in neurology treatments due to lockdowns. However, the situation has improved, with elective surgeries resuming, thereby boosting the utilization of neurology devices. The aging population in the Netherlands, particularly those over 65, is expected to rise significantly, leading to a higher prevalence of cognitive impairments and dementia. This demographic shift is anticipated to fuel market expansion, as more individuals seek advanced neurotherapy solutions.
The market is characterized by a competitive landscape with numerous players engaged in research and development of innovative neuromodulation techniques and minimally invasive procedures. The presence of organizations like the Dutch Brain Foundation has heightened awareness and research into neurological diseases, further propelling market growth. Key companies such as B. Braun Melsungen AG, Boston Scientific Corporation, and Medtronic PLC are actively developing novel devices to capture market share. Recent advancements, such as the CE Mark approval for Brain Scientific's NeuroCap and Braintale's brainTale-care platform, underscore the ongoing innovation within the industry. These developments are expected to contribute to the market's robust growth trajectory over the forecast period.
Netherlands Neurology Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increase in Incidence of Neurological Disorders
-
1.2.2 Huge Investments by Private Players in Neurology Devices
-
1.2.3 Increase in R&D in the Field of Neurotherapies
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Equipment
-
1.3.2 Stringent FDA Validation and Guidelines for New Devices
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Type of Device
-
2.1.1 Cerebrospinal Fluid Management Devices
-
2.1.2 Interventional Neurology Devices
-
2.1.3 Neurosurgery Devices
-
2.1.4 Neurostimulation Devices
-
2.1.5 Other Types of Devices
-
-
Netherlands Neurology Devices Market Size FAQs
What is the current Netherlands Neurology Devices Market size?
The Netherlands Neurology Devices Market is projected to register a CAGR of 4.40% during the forecast period (2024-2029)
Who are the key players in Netherlands Neurology Devices Market?
B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC and Abbott Laboratories are the major companies operating in the Netherlands Neurology Devices Market.
